Mary Ellen Smith
Known title: DirectorCIK: 0001791994
Associated companies
Transaction History
| OPLN | ▲ Buy | Grant | 773 | $26K | 9/30/2026 | View on chart |
| OPLN | ▲ Buy | Grant | 607 | $25K | 6/30/2026 | View on chart |
| OPLN | ▲ Buy | Grant | 858 | $25K | 3/31/2026 | View on chart |
| OPLN | ▲ Buy | Grant | 777 | $23K | 12/31/2025 | View on chart |
| OPLN | ▲ Buy | Grant | 804 | $23K | 9/30/2025 | View on chart |
| OPLN | ▲ Buy | Grant | 946 | $23K | 6/30/2025 | View on chart |
| OPLN | ▲ Buy | Grant | 1,200 | $23K | 3/31/2025 | View on chart |
| OPLN | ▲ Buy | Grant | 1,166 | $23K | 12/31/2024 | View on chart |
| OPLN | ▲ Buy | Grant | 1,370 | $23K | 9/30/2024 | View on chart |
| OPLN | ▲ Buy | Grant | 1,394 | $23K | 6/30/2024 | View on chart |
| OPLN | ▲ Buy | Grant | 1,337 | $23K | 3/31/2024 | View on chart |
| OPLN | ▲ Buy | Grant | 1,773 | $23K | 12/31/2022 | View on chart |
| OPLN | ▲ Buy | Grant | 2,071 | $23K | 9/30/2022 | View on chart |
| OPLN | ▲ Buy | Grant | 1,566 | $23K | 6/30/2022 | View on chart |
| OPLN | ▲ Buy | Grant | 1,282 | $23K | 3/31/2022 | View on chart |
| OPLN | ▲ Buy | Grant | 1,481 | $23K | 12/31/2021 | View on chart |
| OPLN | ▲ Buy | Grant | 1,411 | $23K | 9/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
OPENLANE to report Q3 2026 earnings soon
OPENLANE has announced it will release its third-quarter 2026 earnings. This upcoming report is a key event for the stock, as it will provide updated financial results. Some analysts currently view the shares as potentially undervalued following recent updates, though the company trades within a wide 52-week range.
OPENLANE to report Q3 2026 earnings soon. OPENLANE has announced it will release its third-quarter 2026 earnings. This upcoming report is a key event for the stock, as it will provide updated financial results. Some analysts currently view the shares as potentially undervalued following recent updates, though the company trades within a wide 52-week range.